Antibacterial Resistance Leadership Group (ARLG) begins clinical trial of phage therapy for cystic fibrosis
The trial is evaluating whether the bacteriophage, or “phage,” therapy is safe and able to reduce the amount of bacteria in the lungs of volunteers
